ישראל - עברית - Ministry of Health

pfizer pharmaceuticals israel ltd - crizotinib - קפסולות - crizotinib 200 mg - crizotinib - crizotinib - xalkori is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (nsclc) that is anaplastic lymphoma kinase (alk)-positive.

ישראל - עברית - Ministry of Health

pfizer pharmaceuticals israel ltd - crizotinib - קפסולות - crizotinib 200 mg - crizotinib - crizotinib - xalkori is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (nsclc) that is anaplastic lymphoma kinase (alk)-positive.

ישראל - עברית - Ministry of Health

pfizer pharmaceuticals israel ltd - crizotinib - קפסולות - crizotinib 250 mg - crizotinib - crizotinib - xalkori is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (nsclc) that is anaplastic lymphoma kinase (alk)-positive.

ישראל - עברית - Ministry of Health

pfizer pharmaceuticals israel ltd - crizotinib - קפסולות - crizotinib 250 mg - crizotinib - crizotinib - xalkori is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (nsclc) that is anaplastic lymphoma kinase (alk)-positive.

ישראל - עברית - Ministry of Health

roche pharmaceuticals (israel) ltd - alectinib as hydrochloride - קפסולות - alectinib as hydrochloride 150 mg

ישראל - עברית - Ministry of Health

takeda israel ltd - brigatinib - טבליות מצופות פילם - brigatinib 30 mg - brigatinib

ישראל - עברית - Ministry of Health

takeda israel ltd - brigatinib - טבליות מצופות פילם - brigatinib 30 mg - brigatinib

ישראל - עברית - Ministry of Health

takeda israel ltd - brigatinib - טבליות מצופות פילם - brigatinib 90 mg - brigatinib

ישראל - עברית - Ministry of Health

takeda israel ltd - brigatinib - טבליות מצופות פילם - brigatinib 90 mg - brigatinib

ישראל - עברית - Ministry of Health

novartis israel ltd - ceritinib - קפסולות ג'לטין קשיחות - ceritinib 150 mg - ceritinib